Single-cell Analysis Market Global Key Players, Demands, Trends, Growth Analysis and Forecasts 2023-2028

The global single-cell analysis market size is projected to reach USD 7.1 billion by 2028 from USD 3.5 billion in 2023, at a CAGR of 15.3% during the forecast period. The development of new and advanced single-cell analysis technologies, such microfluidics, droplet-based methods, and high-throughput sequencing platforms, is driving the growth of the market. Additionally, the increasing focus on personalized medicine, governments and private organizations' investments in life sciences and biotechnology research are driving the demand for single-cell analysis products and technologies.

Request Free Sample Report or PDF Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=526898

"The consumables segment is likely to grow at highest CAGR during the forecast period of 2023-2028."

On the basis of product, the single-cell analysis market is segmented into consumables and instruments. The consumables segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to increasing demand of consumables in cell based research. High-throughput single-cell analysis technologies, such as droplet-based methods and microfluidics, require consumables like microfluidic chips, reagents, and beads for efficient cell capture, barcoding, and processing. As these technologies gain popularity and researchers seek to analyze larger numbers of single cells simultaneously, the demand for consumables increases. Sample preparation is a critical step in single-cell analysis, and consumables play a crucial role in cell isolation, lysis, and extraction of nucleic acids. Consumables such as cell separation reagents, extraction kits, and reaction tubes are necessary for efficient and reliable single-cell isolation and preparation, contributing to the growth of the consumables segment. Consumables, including pre-optimized kits, plates, and tubes, help streamline and standardize the experimental workflow, improving efficiency and reducing variability in single-cell analysis. Researchers often prefer consumables specifically designed for single-cell applications to ensure consistent and accurate results.

"The human cells segment is expected to hold a dominant share in 2023."

Based on the cell type, the market is segmented into human cells, animal cells and microbial cells. The human cells segment is expected to hold a dominant share during the forecast period due to increasing interest in human diseases research. Understanding the cellular heterogeneity within human tissues and organs is crucial for advancing our understanding of various diseases and developing targeted therapies. Single-cell analysis allows researchers to study the genetic, epigenetic, and phenotypic differences between individual cells within human tissues, enabling a deeper understanding of disease mechanisms. This has led to increased demand for single-cell analysis of human cells.

"The next-generation sequencing segment is likely to grow at highest CAGR during the forecast period of 2023-2028."

On the basis of technique, the market is segmented into flow cytometry, next-generation sequencing, polymerase chain reaction, microscopy, mass spectrometry, and other techniques. The next-generation sequencing segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to its high-throughput sequencing capabilities, allowing researchers to analyze the genetic material of thousands of individual cells simultaneously.

"In 2022, the research applications segment held a dominant share."

Based on application, the single-cell analysis market is segmented into research applications, and medical applications. The research applications segment held a dominant share of the single-cell analysis market. The research applications of single-cell analysis include cancer research, immunology research, neurology research, stem cell research, and other research applications such as tissue regeneration, virology, drug discovery, and research on aging. Single-cell analysis has revolutionized basic biological research by providing unprecedented insights into cellular functions and interactions. It enables researchers to discover new cell types, identify rare cell populations, and map cell lineages.

"The academic & research laboratories segment is likely to grow at highest CAGR during the forecast period of 2023-2028."

Based on end user, the single-cell analysis market is segmented into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals and diagnostic laboratories, and cell banks & IVF centers. The academic & research laboratories segment to grow at the highest CAGR during the forecast period. Increasing imphasis on research is one of the major factors anticipated to project market growth.

"Asia Pacific region is likely to grow at faster pace."

The single-cell analysis market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of single-cell analysis market. The dominance of the region is attributable to various factors such as the presence of dominant & key market players in the region, and technological advancements. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the growing population, and government initiatives for infrastructural improvements of healthcare facilities are driving market growth in this region.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 80%, and Demand Side -20%
By Designation (Supply Side): Managers - 35%, CXOs & Directors - 20%, Executives- 45%
By Region: North America -25%, Europe -30%, Asia-Pacific -30%, Latin America -10%, and Middle East and Africa -5%

Lists of Companies Profiled in the Report:
Becton, Dickinson and Company (US)
Danaher Corporation (US)
Merck KGaA (Germany)
QIAGEN N.V. (Netherlands)
Thermo Fisher Scientific, Inc. (US)
10x Genomics (US)
Promega Corporation (US)
Illumina, Inc. (US)
Bio-Rad Laboratories (US)
Standard BioTools (US)
Agilent Technologies, Inc. (US)
Tecan Group Ltd. (Switzerland)
Sartorius AG (Germany)
DiaSorin S.p.A. (Italy)
Takara Bio, Inc. (Japan)
Fluxion Biosciences (US)
Menarini Silicon Biosystems Inc. (Italy)
bioMérieux SA (France)
Oxford Nanopore Technologies (UK)
Cytek Biosciences (US)
Corning Incorporated (US)
Apogee Flow Systems Ltd. (UK)
NanoCellect Biomedical (US)
RareCyte, Inc. (US)
On-chip Biotechnologies Co., Ltd. (Japan).

Research Coverage:
This report provides a detailed picture of the single-cell analysis market. It aims at estimating the size and future growth potential of the market across different segments, such as product, cell type, technique, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Direct Purchase of the Global Single-cell Analysis Market Research Report (Use Available 25% Discount Coupon Code: DIS25) https://www.reportsnreports.com/purchase.aspx?name=526898

+ 1 347 333 3771
sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

This release was published on openPR.